Mellanox® Technologies, Ltd. (NASDAQ: MLNX), a leading supplier of high-performance, end-to-end interconnect solutions for data center servers and storage systems, today announced that customer...

Clinical trials need a matchmaker. Healthcare researchers and pharmaceutical companies rely on trials to validate new, potentially life-saving therapies for cancer and other serious conditions. But fewer than 10 percent of cancer patients ...

How NVIDIA’s leading the way with ray tracing, deep learning, cloud gaming and a host of other innovations spilling out to more gamers, on more platforms, than ever. The post Now That Everyone’s a Gamer, New Gaming Technologies Matter More Than Ever ...

Pathology, the study and diagnosis of disease, is a growth industry. As the global population ages and diseases such as cancer become more prevalent, demand for keen-eyed pathologists who can analyze medical images is on the rise. In the U.K. alone, ...

Mellanox Technologies, Ltd. (NASDAQ: MLNX), a leading supplier of high-performance, end-to-end smart interconnect solutions for data center servers and storage systems, today announced that it...

NVIDIA has decided to shift GTC 2020 on March 22-26 to an online event due to growing concern over the coronavirus. This decision to move the event online instead of at the San Jose Convention Center reflects our top priority: the health and safety ...

Twice Sahar Arshad’s father-in-law went to an emergency room in Pakistan complaining of frequent headaches. Twice doctors sent him home with a diagnosis of allergies. Turns out he was suffering from a subdural hematoma — bleeding inside the head. ...

Mellanox Technologies, Ltd. (NASDAQ: MLNX), a leading supplier of high-performance, end-to-end smart interconnect solutions for data center servers and storage systems, today announced the...

Giving what we love about PC gaming to more people. That’s the vision that inspired our journey to develop GeForce NOW into an open platform that welcomed gamers, developers and publishers. For gamers, we provide the power of a GeForce GPU to play ...

Bringing a new medical treatment to market is a slow, laborious process — and for a good reason: patient safety is the top priority. But when recruiting patients to test promising treatments in clinical trials, the faster the better. “Many people in ...